Stock Research: Pro Medicus

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Pro Medicus

ASX:PME AU000000PME8
50
  • Value
    11
  • Growth
    97
  • Safety
    Safety
    11
  • Combined
    18
  • Sentiment
    53
  • 360° View
    360° View
    50
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Pro Medicus Limited is a healthcare informatics company providing medical imaging software and services. It operates in the medical imaging software industry with products like Visage RIS, Visage 7, and Visage Ease. The company serves hospitals, imaging centers, and healthcare groups in Australia, North America, and Europe. In the last fiscal year, the company had a market cap of $22457 million, profits of $111 million, and revenue of $111 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 50 (better than 50% compared with alternatives), overall professional sentiment and financial characteristics for the stock Pro Medicus are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Pro Medicus. The consolidated Growth Rank has a good rank of 97, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 97% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 53, which means that professional investors are more optimistic about the stock than for 53% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 11, which means that the share price of Pro Medicus is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 89% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 11, which means that the company has a financing structure that is riskier than those of 89% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
ASX 200
ASX 300
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
11 5 10 17
Growth
97 99 97 87
Safety
Safety
11 11 83 83
Sentiment
53 81 66 54
360° View
360° View
50 50 78 62
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
15 5 15 13
Opinions Change
50 91 40 50
Pro Holdings
n/a 83 84 42
Market Pulse
82 82 89 90
Sentiment
53 81 66 54
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
11 5 10 17
Growth
97 99 97 87
Safety Safety
11 11 83 83
Combined
18 18 86 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
3 3 10 14
Price vs. Earnings (P/E)
1 1 1 2
Price vs. Book (P/B)
1 1 1 3
Dividend Yield
55 48 57 64
Value
11 5 10 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
94 96 81 46
Profit Growth
72 64 60 62
Capital Growth
60 65 89 94
Stock Returns
91 99 87 81
Growth
97 99 97 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
90 91 89 73
Refinancing
11 17 11 11
Liquidity
15 15 91 91
Safety Safety
11 11 83 83

Similar Stocks

Discover high‑ranked alternatives to Pro Medicus and broaden your portfolio horizons.

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

Flight Centre Travel

ASX:FLT
Country: Australia
Industry: Hotels, Resorts & Cruise Lines
Size: Medium
Full Stock Analysis

MediPal Holdings

TSE:7459
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.